all ( 14 results found)
DHPC - Risk of secondary malignancy of T-cell origin in CD19- or BCMA-directed CAR T-cell therapies
Dzuveo cover letter
Dzuveo DHCP letter
EpiPen® Healthcare Professional Letter
EpiPen® Healthcare Professional Letter
Fluoroquinolones DHPC_HPRA_FINAL vs2 30-05-23
Infanrix Hexa - DHPC
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Vabysmo DHPC dated 17 Oct 2024
Zolgensma (onasemnogene abeparvovec): Important Safety Information